Recently, the amyloid and tau imaging technique using positron emission tomography (PET) has become widely used for the differential diagnosis of dementia and is considered to be important particularly for diagnosis of Alzheimer’s disease (AD) [1]. This evidence concerns the gene MAPT and Alzheimer disease.